AFL Today: Cats or Lions to claw ahead in the big grand FELINE final?
Health Check: Aft’s revenue and drug-development ambitions are running to plan
Suburban backyards are a gold mine for savvy investors
Barrick’s Fourmile discovery could be the gold find of the century – these ASX explorers are looking for the next one
Bulk Buys: Simandou is finally coming. Here’s how it could shake up iron ore markets
Caspin pairs tin and gold projects to deliver multiple pathways to mining success
Explorers Podcast: Javelin Minerals looks to Eureka for first Kalgoorlie gold dig
Explorers Podcast: TG Metals ramps up Van Uden gold drilling with resource growth in sight
Long Shortz with GoldArc Resources: Growing gold ounces in the Eastern Goldfields
Rise and Shine: Everything you need to know before the ASX opens
Contributors
Our Resident Experts
Mining
Bulk Buys: Simandou is finally coming. Here’s how it could shake up iron ore markets
Caspin pairs tin and gold projects to deliver multiple pathways to mining success
Explorers Podcast: Javelin Minerals looks to Eureka for first Kalgoorlie gold dig
Explorers Podcast: TG Metals ramps up Van Uden gold drilling with resource growth in sight
Resources Top 5: Everlast blasts out of blocks with strong backing for mineral sands strategy
Tech
EMVision’s latest cap raise gets strong backing – here’s why this investor sees upside
Australian car buyers face complex choice in EV revolution
AI will make your children better investors than you
Aussie ‘cultural cringe’ hiding quantum computing success
The hidden toll of hearing loss, and one ASX stock tuned in to solutions
Featured in Tech
Health & Biotech
Health Check: Imagion is crossing the t’s and dotting the i’s on crucial breast imaging trial submission
Biocurious: How to get a five-fingered discount without robbing a store
US FDA medical device clearance demystified – what investors need to know
Health Check: Clinuvel, Telix shares surge on regulatory breakthroughs in Europe and US
Dr Boreham’s Crucible: One clear shot on goal for this cancer drug hopeful
Featured in Health & Biotech
Experts
Super’s ages and stages: what you need to know
Precision Points: Dermot Woods teaches you the simplest way to value a stock
Top adviser backs private markets but says ‘keep eyes open’ to risks
Adding up the costs of modern life shows how tough it is for today’s generation
Stock Tips: Some pretty Flash resources-extraction tech is in frame this week
Criterion: Under revamped ownership, SPC Global cans its ‘baked beans and spaghetti’ reputation
ASX Small Caps Weekly Form Guide
